ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

HPV Can Affect Response To Radiation Therapies

September 28, 2012

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

Eight Probable Minority CCOP Awardees Lister; NCI May Award As Many As 12, With 220 Payline

June 1, 1990

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010